Pharmaceutical Company CEOs Face Grilling in Senate Over High Drug Prices

Sen. Ron Wyden, D-Ore., left, and Sen. Chuck Grassley, R-Iowa, right, chairman of the Senate Finance Committee, asked drug company CEOs some tough questions on drug prices on Tuesday, during a hearing before the Senate Finance Committee.

Senators called pharmaceutical industry leaders to account for the high costs of medicine during Senate testimony. The executives deflected blame to insurance companies and middlemen.

(Image credit: Pablo Martinez Monsivais/AP)

Read the full post on Health Care : NPR